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Abstract. The disruption of interactions between ex- 
tracellular matrix and specific cognate integrins triggers 
apoptosis in epithelial cells, in a process termed 
"anoikis." To understand anoikis, the connections be- 
tween epithelial cell integrin signaling and the apopto- 
sis-regulatory proteins are being explored. We report 
herein that early after detachment from matrix, epithe- 
lial cells activate Jun-N-Terminal Kinases (JNKs; alter- 
natively known as Stress-activated Protein Kinases), 
which are also activated by other apoptotic stimuli. The 
activity of this pathway was required for anoikis. An- 
other early response to cell suspension was the activa- 
tion of the ICE-related cysteine protease, ICE/LAP3; 
this activation and anoikis were suppressed by the ICE- 
protease inhibitor, crmA. The overexpression of bcl-2 
suppressed ICE/LAP3 activation as well. Surprisingly, 
bcl-2 and crmA attenuated the activation of JNKs fol- 
lowing cell suspension, suggesting that the JNK path- 
way is regulated directly or indirectly by proteolysis. In 
addition, the blockage of the JNK pathway attenuated 
the activation of ICE/LAP3, suggesting a positive feed- 
back loop between the ICE and JNK systems. These re- 
suits indicate the following sequence of information 
flow in anoikis: integrins~bcl-2/bax~(ICE-pro- 
teases~-.JNK)~apoptosis. Cell--cell interactions, which 
were previously shown to sensitize cells to anoikis, 
caused bcl-2 mRNA to be downregulated, a permissive 
event for downstream apoptotic signaling. 
T 
HE acquisition of anchorage independence (Shin et al., 
1975)  and  apoptosis  resistance  (Thompson,  1995; 
Kerr et al., 1994; Fisher, 1994; Reed, 1995) are criti- 
cal for tumor malignancy. The concept of anoikis (for re- 
view see Ruoslahti and Reed, 1994) explains how apoptosis 
resistance can lead to anchorage independence of epithe- 
lial (Frisch, Francis, 1994) and endothelial (Meredith et al., 
1993) cells. 
An understanding of anoikis will require the elucidation 
of the mechanisms for integrin signaling in epithelial cells 
and how these connect with apoptosis-regulatory proteins. 
Cell shape, regulated by integrin-matrix interactions, is an 
important link between integrins and apoptosis (Re et al., 
1994) that can be considered one form of integrin signal- 
ing. However, the inappropriate activation of certain inte- 
grin signaling molecules can bypass the cell shape require- 
ment  for  the  suppression  of  apoptosis,  as  it  occurs  in 
oncogenic transformation. For example, we have recently 
shown that an experimentally activated form of focal ad- 
hesion kinase (FAK)  1 can render certain epithelial cells 
anoikis-resistant  and  transformed  (Frisch  et  al.,  1996). 
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Conversely, a tumor suppressor gene that transcriptionally 
programs an epithelial phenotype (Ela)  renders human 
carcinoma  or  sarcoma  cells  anoikis-sensitive  and  non- 
transformed (Frisch, 1994; Frisch, 1991; Frisch and Dolter, 
1995). 
Studies of integrin signaling in fibroblasts have indicated 
that cell-matrix adhesion causes a transient activation of 
the ERK1,2 enzymes of the MAP kinase family (Chen et al., 
1994). This has been proposed to occur via the binding of 
FAK to c-src family proteins (Cobb et al., 1994) and/or nu- 
cleotide-exchange factors for ras (Schlaepfer et al., 1994). 
In  an  epithelial cell system, however,  the  activation of 
ERK1,2 in response to cell-matrix interaction was not evi- 
dent, nor was it enhanced by expression of an activated 
form of FAK (Frisch et al., 1996). This motivated us to ex- 
amine  alternative  protein  kinase  signaling  events  that 
might relate to anoikis. 
JNKs  (alternatively known  as  SAPK,  Stress-activated 
Protein Kinases) have previously been shown to be acti- 
vated by various apoptotic stimuli such as ultraviolet light, 
interleukin-1, tumor necrosis factor-et, and ~/-irradiation 
(Davis, 1994; Derijard et al., 1994; Verheij et al., 1996). In 
the present study, we report that JNKs are also activated 
by the disruption of integrin-mediated cell-matrix interac- 
tions, and that this activation is required for anoikis. We 
further show that bcl-2 and crmA attenuate the JNK acti- 
vation, which functionally links the bcl-2/bax,  ICE,  and 
JNK pathways. 
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Construction of Cell Lines 
The wild-type and dominant-negative (Whitmarsh et al., 1995) FLAG- 
epitope-tagged JNKK coding sequences were provided by R. Davis, Uni- 
versity of Massachusetts; bcl-2 wild-type and point mutant 145 coding 
sequences (Hanada et al., 1994) were provided by J. Reed (the Burnham 
Institute, La Jolla, CA); crmA wild-type and crmA point mutant 291 cod- 
ing sequences (Tewari et al., 1995), provided by G. Salvesen, the Burnham 
Institute were subcloned into the retrovirus vector pBABEpuro (Morgen- 
stern and Land, 1990), provided by H. Land and packaged amphotropi- 
cally in Bing cells (American Type Culture Collection, Rockville, MD) as 
described (Pear et al., 1993). 2 d after transfection, viral supernatants were 
applied to MDCK cells, which were then selected for 10 d in 1.75 p,g/ml 
puromycin. Individual colonies were picked, expanded, and tested for ex- 
pression of the transgene by Western blotting. For all experiments re- 
ported here, two to three independently derived cell lines of each type 
were tested at least twice; however, for brevity, only one representative 
result is shown. The ras(vall2)-transformed MDCK cells were described 
previously (Frisch and Francis, 1994). 
Western Blot Analysis 
Western blots were performed as described previously (Frisch,  1994) us- 
ing antibodies from the following  sources:  anti-FLAG M2 (IBI-Kodak, 
Rochester, NY); anti-bcl-2 COOH  terminus and anti-JNK (Santa Cruz 
Biotechnology, Santa Cruz, CA); anti-crmA (D. Pickup, Duke Univer- 
sity); and anti-ICE/LAP3 (V. Dixit, University of Michigan). 
JNK Assays 
JNK activity was assayed as described (Derijard et al., 1994) using the 
"pull-down" method wherein GST-jun fusion protein is used to affinity- 
select JNK  enzyme before the kinase  reaction. Cells were  not serum 
starved before induction by cell suspension. Within each experiment, an 
equal amount of protein (determined by Bio-Rad protein assays) was as- 
sayed for each sample. Quantitative results were obtained using a GS250 
phosphorimager (Bio-Rad Labs, Hercules, CA). For the immune complex 
kinase assay (Derijard et al.,  1994) of JNK, anti-JNK antibody (Santa 
Cruz Biotechnology) was used. 
Anoikis Assays 
Cells were assayed for anoikis by agarose gel analysis of internucleosomal 
DNA cleavage as described previously (Frisch and Francis, 1994), except 
that the assay used 0.5 ×  106 cells suspended in 2.0 ml of growth medium 
in a microfuge tube for 3.5 h with slow rotation at 37°C. The loading vol- 
umes for the DNA ladder analysis were normalized against the amount of 
Triton-soluble protein present in the sample before phenol extraction. 
RT-PCR Analysis 
RT-PCR was performed as described (Ausubel et al., 1994) using the fol- 
lowing primers: TGCCACCTGTGGTCCACCTGACCC~C (bcl-2 forward); 
TTCAGAGACAGCCAGGAGAAATC (bcl-2 reverse); CAGGATGC- 
GTCCACCAAGAAGCTG  (bax forward); TCAGCCCATCTrCrrC- 
CAGATGG (bax reverse). 
Results 
Suspension of  MDCK Cells Induces JNK Activity 
We showed previously that 3-5 h of cell suspension irre- 
versibly committed MDCK cells to  anoikis  (Frisch  and 
Francis, 1994). Various methods of detachment (EDTA, 
trypsin, and RGD peptides) produced similar results; for 
convenience, trypsinization was used in this study. We also 
showed that cell-cell interactions sensitized cells to anoikis; 
thus, cells became apoptotic after suspension only if they 
were confluent before suspension. 
Jun-N-terminal  kinase  (JNK)  activity was  assayed in 
cells that were grown to subconfluence or confluence and 
subsequently placed  in  suspension.  In  parallel  with the 
anoikis response, JNK activity was rapidly and strongly in- 
duced by the suspension of confluent cells but not subcon- 
fluent cells (Fig. 1 A). This result indicated that JNK is in- 
duced by the disruption of cell-matrix interactions, and 
that this effect is modulated by cell-cell interactions, sug- 
gesting a possible role for JNK in anoikis. 
While the substrate that we used for the JNK assays, 
c-jun  amino  acids  1-223,  contains  residues  specifically 
phosphorylated by JNK (Derijard et al., 1994), it was for- 
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Figure 1.  JNK activity is induced by the disruption of cell-matrix 
interactions (cell suspension). (A) Cell-cell interactions sensitize 
JNK to being activated by disruption of cell-matrix interactions. 
MDCK  cells grown to  confluence or subconfluence (~30%  of 
confluent cell density) were assayed for JNK activity, using the 
pull-down assay described in Materials and Methods, either un- 
der attached conditions (att) or after cell suspension for the times 
indicated (min). (B) The jun-kinase activity induced by cell sus- 
pension is JNK.  Immune complex kinase assays using anti-JNK 
antibody were performed on cells held in suspension for the indi- 
cated times. (C) Cell suspension does not induce JNK protein ex- 
pression. Attached or suspended MDCK cells were lysed and an- 
alyzed on a Western blot for JNK expression; a control blot using 
anti-tubulin antibody demonstrated equal protein loading (data 
not shown). 
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scored. However, when JNK activity in suspended MDCK 
cells was assayed alternatively by an immune-complex ki- 
nase assay using a JNK(1,2)-specific antibody, similar re- 
sults were obtained (Fig. 1 B), confirming that the kinase 
activity was JNK specifically. 
When cells were replated on collagen-coated plates (at 
high density) after trypsinization and neutralization, JNK 
activity was not induced (Fig. 1 B). This result, and the ef- 
fect of cell density noted above, indicate that JNK activity 
is induced by suspension and not by trypsin treatment. 
To verify that the induced JNK activity was due to sig- 
naling rather than de novo synthesis of new JNK protein, 
Western blots were performed. The level of JNK protein 
was neither affected by suspension (Fig. 1 C) nor by cell 
density (data not shown). 
CeU-CeU Interaction Regulates the Expression 
of bcl-2 mRNA 
Cell--cell interaction before cell suspension sensitizes MDCK 
cells with respect to anoikis (Frisch and Francis, 1994). Be- 
cause the ratios of bcl-2 to bax protein in cells are thought 
to govern their sensitivity to apoptosis (Reed, 1995), the 
levels of bcl-2 and bax mRNAs  were assayed in a  non- 
quantitative fashion by RT-PCR. Interestingly, we found 
that bcl-2 mRNA was detectable in subconfluent MDCK 
cells, which were also resistant to anoikis and refractory to 
JNK induction. However, confluent MDCK cells---which 
were  sensitive  to  anoikis  and  had  suspension-inducible 
JNK activity--had no detectable bcl-2 mRNA at the level 
of sensitivity of our assay (Fig. 2). The level of bax mRNA, 
however, remained  constant.  The  canine  bcl-2  and  bax 
proteins were not reactive with any anti-human or anti-rodent 
antibodies tested, prohibiting measurement of the protein 
levels. 
These results indicate the levels of bcl-2 mRNA were 
regulated  by cell-cell interactions.  This  decrease  corre- 
lated with the onset of sensitivity to anoikis and with the 
sensitivity of JNK to activation by cell suspension. 
Bcl-2 Suppresses Suspension-induced JNK Activity 
The results above (although purely a correlation between 
bcl-2 mRNA  levels and JNK  activation) suggested  that 
perhaps bcl-2 regulated the sensitivity of the JNK pathway 
to induction  by cell suspension.  To test this  possibility, 
MDCK cells were constructed that overexpressed either 
the wild-type bcl-2 protein or a point mutant (bel-2mut145) 
that is incapable of dimerizing with bax or suppressing ap- 
optosis (Hanada et al., 1995). The bcl-2 (wild-type) cells 
were  substantially  resistant  to  anoikis,  while  the  bcl-2 
(rout145) cells were fully sensitive (Fig. 3). Interestingly, 
bcl-2 (wild-type), but not bcl-2(mut145), attenuated (~5.6- 
fold) the induction of JNK activity by cell suspension (Fig. 
4  A).  Western  blot  analysis  showed that  overexpressed 
bcl-2 did not affect JNK protein levels (Fig. 4 B), suggest- 
ing that  bcl-2 blocks some  aspect  of the  JNK  signaling 
pathway. 
Bcl-2 and crmA Suppress the Activation of ICEILAP3 
The effect of bcl-2 on JNK activation motivated experi- 
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Figure 2.  Cell-cell  interactions  downregulate  bcl-2 mRNA ex- 
pression. MDCK cells grown in monolayers of low, medium, or 
high density were analyzed for bcl-2 and bax mRNA expression 
by RT-PCR reactions on equal amounts of total RNA using the 
appropriate primers. Cells on parallel dishes grown to each den- 
sity were trypsinized and placed in suspension for 30 rain or 3.5 h, 
after which protein lysates in JNK extraction buffer or low molec- 
ular weight DNA were prepared and assayed for JNK activity or 
apoptotic DNA ladders, respectively. 
ments to test whether other apoptosis modulatory proteins 
might affect the JNK pathway as well. The cowpox virus 
protein, crmA, has previously been shown to inhibit apop- 
tosis in many systems, including mammary epithelial cells 
bound to fibronectin (Boudreau et al., 1995). CrmA binds 
and inhibits cysteine proteases of the ICE family (Tewari 
et al., 1995a,b). MDCK cells were constructed that expressed 
either  the  wild-type  form  of crmA  or  a  point  mutant 
(crmAmut291) previously shown to lack protease-inhibi- 
tory activity (Tewari et al., 1995a). The crmA (wild-type) 
MDCK cells were substantially resistant to anoikis, while 
the crmA (mut291) cells were fully sensitive (Fig. 3 A). 
Previous reports have proposed that bcl-2 directly or in- 
directly regulates the activity of the ICE system cascade 
(Chinnaiyan  et  al.,  1996;  Shimizu  et  al.,  1996).  To test 
whether this applied to anoikis as well, MDCK cells ex- 
pressing ectopic bcl-2 or crmA proteins were placed in sus- 
pension.  Protein lysates were then analyzed on Western 
blots for the presence of the activated p20 subunit of the 
YAMA-like protease, ICE/LAP3 (Duan et al., 1996). As 
expected, p20 was undetectable in attached cells, but ap- 
peared  in  suspended,  control  MDCK  cells  (Fig.  3  B); 
crmA-expressing cells failed to produce p20, presumably 
because ICE proteases required for ICE/LAP-3 process- 
ing were inhibited. Bcl-2-overexpressing cells also failed 
to produce p20, which, consistent with recent reports, sug- 
gested that bcl-2 can suppress the proteolytic activation of 
YAMA-like proteases. 
crmA and Activated ras Suppress Suspension-induced 
JNK Activity 
The results above indicated that bcl-2 inhibited the activa- 
tion of at least a component of the ICE-like protease cas- 
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Figure  3.  (A)  Bcl-2, crmA, 
and dominant-negative JNKK 
(]nkk-dn)  suppress  anoikis. 
Anoikis  assays were  per- 
formed on stable, retrovirus- 
transduced  cell lines as  de- 
scribed  in  Materials  and 
Methods. The percent  apop- 
tosis for  three  types  of cell 
lines were  obtained by flow 
cytometry of  propidium  io- 
dide-stained cells (which are 
likely to represent underesti- 
mates).  The  fight-hand 
panel  depicts anoikis assays 
conducted at later suspension 
time points. (B) Bcl-2, crmA, 
and jnkk-dn inhibit the acti- 
vation  of  ICE/LAP3. 
MDCK  cells containing  the 
indicated  ectopic  genes  and 
grown  under  normal  at- 
tached  conditions  (art) or 
held  in  suspension  for  2  h 
were  analyzed  by  Western 
blotting  using  anti-I CE/ 
LAP3  polyclonal  antibody. 
The  ICE/LAP3 p20 subunit, 
resulting from proteolytic ac- 
tivation  by  upstream  pro- 
teases, is shown. 
cade and inhibited the activation of JNK as well. This sug- 
gested  that  perhaps  the  ICE-like  protease  cascade  was 
required for JNK activation. 
This possibility was tested using the cell lines described 
above. Interestingly, crmA (wild-type), but not crmA(mut 
291) attenuated (approximately eightfold) the induction of 
JNK by cell suspension; Western blot analysis (Fig. 4 B) 
showed that crmA did not affect JNK protein levels. 
Transformation  of the  MDCK  cells  with  an  activated 
form of c-ha-ras (rasV12) both alleviated anoikis and sup- 
pressed  the  activation  of JNK,  suggesting  crosstalk  be- 
tween some component of the ras-raf-MAPK pathway and 
the JNK pathway. 
JNK Mediates Anoikis 
Cell suspension induced JNK activity by a bcl-2- and crmA- 
sensitive mechanism. If JNK were to mediate anoikis, then 
the suppression of anoikis by bcl-2 and crmA might partly 
be due to their suppression of JNK. The role of the JNK 
pathway  in  anoikis  was  therefore  investigated.  A  previ- 
ously  described  dominant-negative  form  of  JNKK  was 
used, in which serine 257 and threonine 261 were mutated 
to alanines, thereby preventing the phosphorylation of the 
enzyme by MEKK that is required for optimal JNKK ki- 
nase  activity  (Whitmarsh  et  al.,  1995).  MDCK cell  lines 
were constructed that expressed this mutant (JNKK-dn). 
These cells had approximately fourfold reduced JNK ac- 
tivity  after  30  min  of suspension,  compared  with  either 
normal  MDCK  cells  or  cells  expressing  the  wild-type 
JNKK protein (Fig. 4 A). Interestingly, the cells expressing 
the  dominant-negative  JNKK were  also  about  threefold 
more resistant to anoikis when assayed at 3.5 h (Fig. 3 A); 
substantial anoikis resistance was retained for up to 6 h of 
cell suspension. Accompanying this, the activation of ICE/ 
LAP3 was substantially attenuated (Fig. 3 B). 
Discussion 
Integrin Signaling and the JNK Pathway 
In this study, the  connections between integrin signaling 
and apoptosis were explored in the context of anoikis reg- 
ulation.  Several previous reports have indicated  that  the 
ERK-type MAP kinases are stimulated by integrin-medi- 
ated cell adhesion in fibroblasts; this is thought to involve 
FAK  and  ras  signaling  (Chen  et  al.,  1994;  Cobb  et  al., 
1994).  However, we reported previously that ERKs were 
not activated in MDCK cells in response to cell-matrix ad- 
hesion, even in cells containing an activated form of FAK 
(Frisch et al., 1996). This motivated us to examine the role 
of the INK pathway. 
We have now found that JNK is rapidly activated by the 
disruption of cell-matrix interactions in MDCK cells. The 
JNK pathway, also known as the Stress-activated Protein 
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Figure 4.  Bel-2, crmA, JNKK-dorninant  negative,  and c-ha-ras 
(V12) suppress suspension-induced JNK activity. (A) JNK assays 
were performed as in Materials and Methods using 150 Ixg of cell 
extract. Cells were assayed after suspension for 30 min, except in 
attached control (att). (B) Bcl-2 and crmA do not affect the ex- 
pression of JNK protein. The Western blot using anti-JNK anti- 
body was performed on equal mounts of total cell lysate; a par- 
allet  blot using  anti-tubulin  antibody confirmed equal loading 
(data not shown). 
Kinase pathway, is well known to respond to extracellular 
stimuli that induce apoptosis, such as tumor necrosis fac- 
tor--et,  ceramide,  granzyme  B,  interleukin-1,  ultraviolet 
light, and v-irradiation (Davis, 1994; Derijard et al., 1994; 
Verheij et al.,  1996). While this project was in progress, 
several new reports showed that JNK mediated these apop- 
totic  events.  For  example,  the  apoptosis  of PC12  cells 
caused by the withdrawal of nerve growth factor (Lange- 
Carter et al., 1993) and that of ceramide-treated 3T3 cells 
(Verheij et al., 1996) were blocked by dominant-negative 
forms of JNKK.  Analogously, we have shown that JNK 
plays a critical role in mediating anoikis as well. This result 
demonstrates  that  integrin-mediated cell-matrix interac- 
tions regulate well-characterized stress-response pathway. 
By contrast, JNK is induced by cell-matrix adhesion in fi- 
broblasts (Miyamoto et al.,  1995), underscoring the dra- 
matically different integrin signaling pathways in the two 
cell types. 
The mechanism by which the lack of integrin-matrix in- 
teraction triggers JNK activation remains to be elucidated. 
We have considered several possibilities. The first was that 
ceramide perhaps would accumulate in detached cells and 
activate JNK. However, cell suspension was found to in- 
duce  ceramide  accumulation  only in  subconfluent  (i.e., 
anoikis-resistant)  cell cultures, rendering improbable  an 
important role of ceramide in anoikis (data not shown). 
The second possibility was that cdc42 or rac, which can 
stimulate JNK in transiently transfected fibroblasts (Min- 
den et al., 1995), might be altered by cell adhesion so as to 
affect the JNK pathway in epithelial cells. However, defin- 
itive effects of the activated or dominant-negative forms of 
these  molecules  were  not  observed  (data  not  shown). 
Other possible mechanisms for connecting integrins with 
the JNK pathway include changes in cytoskeletal organi- 
zation. 
The mechanisms  by which  JNK  causes  apoptosis  are 
presently unclear as well. However, there are two reports 
that a dominant-negative form of the JNK substrate, c-jun, 
can confer apoptosis resistance (Lange-Carter et al., 1993; 
Verheij et al., 1996), suggesting that the latter may func- 
tion both in apoptosis and transcription. 
Connections Among Three Types of Signaling 
Molecules in Anoikis 
Apoptosis is regulated by at least three types of signaling 
molecules:  (1)  bcl-2-related  proteins  (Reed,  1994);  (2) 
ICE-related proteases  (Takahashi  and Earnshaw,  1996); 
and  (3)  JNK pathway  kinases  (Davis  et  al.,  1994).  Re- 
cently,  it  has  become  clear  that  ICE-related  proteases 
form a proteolytic cascade (reviewed in Fraser and Evan, 
1996).  "Initiator"  proteases,  such  as  the  Fas-associated 
prototype, FLICE (Muzio et al., 1996), are thought to con- 
vert pro-ICE to active ICE. The latter then acts as an "am- 
plifier" protease to convert the pro-forms of the ICE/ced-3 
family (e.g., CPP32/YAMA, ICE/LAP-3, etc.) into the ac- 
tive,  "machinery"  proteases,  which  degrade  substrates 
such as nuclear lamins and polyADP ribose polymerase. 
Other reports have shown that the overexpression of bcl-2 
or bcl-xt can prevent the activation of the machinery and/or 
the amplifier proteases (Chinnaiyan et al., 1996; Shimizu 
et al., 1996). Consistent with this, we have shown that bcl-2 
prevents the  activation of the  machinery protease  ICE/ 
LAP-3; this is presumably one mechanism by which bcl-2 
suppresses anoikis. 
We have also shown that cell--cell interactions cause bcl-2 
expression to be downregulated, sensitizing MDCK cells 
to subsequent  anoikis.  After bcl-2 downregulation, pro- 
teolytic activation of the ICE-like protease cascade and 
apoptosis  are  potentiated; indeed,  the  protease  cascade 
fails to activate when noninteracting MDCK cells are chal- 
lenged with an apoptotic stimulus (data not shown). These 
results underscore the significance of cell-cell interactions 
in regulating the apoptotic sensitivity of epithelial cells in 
vivo. They also prompt an examination of the effect of ab- 
errant cadherin-catenin complexes, often found in carcino- 
mas  (Birchmeier and  Behrens,  1994),  upon  bcl-2 levels 
and the ICE system. 
Perhaps the most novel result of the present study is that 
the activity of the JNK pathway requires ICE-system pro- 
teolytic function and is therefore inhibited by crmA or bcl-2. 
These results have several ramifications. First, they func- 
tionally link the bcl-2, ICE, and JNK systems into a unified 
pathway for apoptotic signaling. Secondly, they motivate 
the search for an ICE-like protease substrate that is pro- 
teolyticaUy activated to switch on the JNK pathway; candi- 
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bcl-2  (or cell-call  interactions)  may  potentially  regulate 
the phosphorylation and transcriptional activity of JNK ki- 
nase-substrates  such as c-jun and ATF-2; in this connec- 
tion, bcl-2 was recently reported to regulate the activity of 
an  NF-KB  kinase  (Grimm et  al.,  1996).  Conversely,  the 
dominant-negative  form of JNKK  attenuated  the activa- 
tion of ICE/LAP3. This indicates that the JNK system is 
connected  with the  ICE  system  via  a  positive  feedback 
loop that may serve to rapidly amplify the apoptotic re- 
sponse. In the future, it will be of interest to determine the 
molecular basis of this feedback loop. 
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